Get the Stockscreener App
24.61
1.46%
-0.355
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Perrigo Company Plc stock is traded at $24.61, with a volume of 225.47K.
It is down -1.46% in the last 24 hours and down -1.38% over the past month.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
See More
Previous Close:
$24.97
Open:
$24.86
24h Volume:
225.47K
Relative Volume:
0.17
Market Cap:
$3.41B
Revenue:
$4.39B
Net Income/Loss:
$-159.70M
P/E Ratio:
-21.04
EPS:
-1.17
Net Cash Flow:
$151.70M
1W Performance:
-1.22%
1M Performance:
-1.38%
6M Performance:
-11.36%
1Y Performance:
-22.89%
1-Day Range:
$24.49
$24.93
1-Week Range:
$24.37
$25.47
52-Week Range:
$23.14
$33.45
Perrigo Company Plc Stock (PRGO) Company Profile
Name
Perrigo Company Plc
Sector
Phone
269-673-8451
Address
THE SHARP BUILDING, DUBLIN 2
Compare PRGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
24.61 | 3.41B | 4.39B | -159.70M | 151.70M | -1.17 |
|
ZTS
Zoetis Inc
|
171.56 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.55 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.545 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.67 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
123.94 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-25 | Downgrade | Argus | Buy → Hold |
| Jan-06-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-24-24 | Resumed | Jefferies | Hold |
| Nov-17-23 | Initiated | Piper Sandler | Overweight |
| Mar-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-14-22 | Upgrade | Argus | Hold → Buy |
| Sep-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-30-21 | Upgrade | Jefferies | Hold → Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Jan-06-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-17-20 | Downgrade | Argus | Buy → Hold |
| Mar-24-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-20-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-18-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-11-19 | Upgrade | Argus | Hold → Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Nov-13-18 | Downgrade | Berenberg | Buy → Hold |
| Aug-10-18 | Reiterated | Stifel | Hold |
| Jul-30-18 | Downgrade | Argus | Buy → Hold |
| Jul-12-18 | Downgrade | Goldman | Neutral → Sell |
| Jan-03-18 | Initiated | Leerink Partners | Mkt Perform |
| Dec-08-17 | Upgrade | Argus | Hold → Buy |
| Nov-10-17 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Oct-05-17 | Reiterated | UBS | Buy |
| Sep-07-17 | Initiated | Oppenheimer | Outperform |
| Aug-11-17 | Upgrade | Goldman | Sell → Neutral |
| Aug-11-17 | Reiterated | RBC Capital Mkts | Underperform |
| Jun-16-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-05-17 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| Mar-03-17 | Reiterated | B. Riley & Co. | Neutral |
View All
Perrigo Company Plc Stock (PRGO) Latest News
Opportunities in the Omeprazole Market, 2025-2030: Dr. - GlobeNewswire
DAVENPORT & Co LLC Cuts Stock Holdings in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet - Simply Wall St
Perrigo Company plc (NYSE:PRGO) Shares Sold by Copeland Capital Management LLC - MarketBeat
Perrigo Company plc (NYSE:PRGO) Shares Acquired by Janney Montgomery Scott LLC - MarketBeat
KBC Group NV Raises Holdings in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships - Quantisnow
Perrigo announces director Katherine Doyle's retirement - MSN
Perrigo announces director Katherine Doyle's retirement By Investing.com - Investing.com UK
SG Americas Securities LLC Invests $691,000 in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025 - Marketscreener.com
Perrigo Sets Stage for Major Strategic Update: Q4 Results and Investor Day Double Header - StockTitan
Perrigo Co. PLC stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Toothbrush Market to hit USD 17.19 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Burn pain Market Expected to rise, 2034 | Johnson & Johnson, - openPR
Strong week for Perrigo (NYSE:PRGO) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance
Perrigo Paves The Way For Recovery With Margin Focus (NYSE:PRGO) - Seeking Alpha
Perrigo Co. PLC stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Sound Income Strategies LLC Purchases 107,427 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat
Nutraceuticals Market: Trends, Insights, and Growth Forecast 2032 | Glanbia Plc, Perrigo Company Plc - EIN News
Nisa Investment Advisors LLC Has $7.84 Million Stock Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Objective long/short (PRGO) Report - Stock Traders Daily
Perrigo Co. PLC stock outperforms competitors despite losses on the day - MarketWatch
Perrigo Co (MEX:PRGO) Earnings Yield (Joel Greenblatt) % : -0.26% (As of Sep. 2024) - GuruFocus.com
Clear Harbor Asset Management LLC Sells 20,410 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat
Here’s White Falcon Capital’s Investment Thesis for Perrigo Company plc (PRGO) - MSN
Perpetual Ltd Reduces Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Perrigo: A Consumer Health Company Close To An Inflection Point - Seeking Alpha
White Falcon Capital Q4 2024 Partner's Letter - Seeking Alpha
Perrigo Co (BSP:P1RG34) Altman Z-Score : 0.67 (As of Jan. 19, 2025) - GuruFocus.com
Perrigo Co (BSP:P1RG34) 3-Year Revenue Growth Rate : 4.90% (As of Sep. 2024) - GuruFocus.com
O Keefe Stevens Advisory Inc. Has $5.09 Million Stock Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat
PRGO (Perrigo Co) Growth Rank : 1 (As of Jan. 19, 2025) - GuruFocus.com
PRGO (Perrigo Co) Median PS Value : $54.95 (As of Jan. 18, 2025) - GuruFocus.com
Perrigo Company plc Appoints Jonas Samuelson to as A Member of Board of Directors and Audit Committee and the Nominating and Governance Committee - Marketscreener.com
Perrigo cut to Hold at Argus on topline risks - MSN
Perrigo Sees Unusually Large Options Volume (NYSE:PRGO) - MarketBeat
Perrigo (NYSE:PRGO) Hits New 12-Month LowHere's What Happened - MarketBeat
Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Perrigo stock cut to hold at Argus on topline risk (PRGO:NYSE) - Seeking Alpha
Perrigo stock hits 52-week low at $23.86 amid market challenges - Investing.com India
Perrigo (NYSE:PRGO) Stock Rating Lowered by Argus - MarketBeat
(PRGO) Investment Report - Stock Traders Daily
JPMorgan Chase & Co. Purchases 213,221 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat
Perrigo (NYSE:PRGO) Lowered to "Hold" Rating by StockNews.com - MarketBeat
Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch
US Consumer Health People Moves: Perrigo Science And Haleon US Customer Chiefs, More - News & Insights
Perrigo Company Plc Stock (PRGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.12%
2.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):